| 영문 | vaccine | 한글 | 백신 |
|---|---|---|---|
| 설명 | 전염병에 대하여 인공적으로 면역을 주기 위해 생체에 투여하는 항원의 하나. 병원체 및 독소에 대한 방어기구를 강화할 목적으로 사용되는 미생물제제를 말한다. 프랑스의 미생물학자 L. 파스퇴르에 의하여 제창된 용어로서, 어떤 감염증에 대하여 인공적으로 면역을 얻기 위하여 그 병원 미생물 또는 그 독소액에 적당한 조작을 가하여 만든 것을 말한다. |
||
| 영문 | poliovirus | 한글 | 폴리오바이러스 |
|---|---|---|---|
| 설명 | 피코루나바이러스과, 엔테로바이러스속의 바이러스이며, 회색척수염(소아마비)의 병원체이다. 1, 2, 3형의 혈청형으로 분류한다. 1형이 전마비성 회백수염의 85%를 차지한다. 외피를 갖지 않는 정이십면체, 직경 25~30μm 이다. 경구적으로 침입한 후 인두와 작은창자에 감염하며, 주로 림프조직(특히 편도와 장관의 집합림프소포)에서 증식하여, 바이러스혈증을 일으키며 전신으로 퍼진다. 감염자의 대부분은 비교적 경증(99%는 불현성 감염)으로 끝나지만, 드물게 바이러스가 혈류를 매체로 뇌의 운동겉질과 척수의 앞뿔세포에 도달하면 마비증상이 나타난다. 마비를 나타내는 증례로는 근육통, 근육강직 등 전구증상이 나오고 즉시 이완성 마비가 나타난다. |
||
| eIPV | enhanced inactivated polio vaccine |
|---|---|
| MOPV | monovalent oral poliovirus vaccine |
| DCS | decompression sickness; dense canalicular system; diffuse cortical sclerosis; dorsal column stimulat... |
| IPV | inactivated poliomyelitis vaccine or virus; infectious pustular vaginitis; infectious pustular vulvo... |
| PVR | peripheral vascular resistance; perspective volume rendering; poliovirus receptor; postvoiding resid... |
| IPV | Inactivated poliovirus vaccine |
|---|---|
| IPV | Inactivated Polio-Vaccine |
| OPV | Oral Poliovirus Vaccine |
| CPDB | Carcinogenic Potency Database |
| R.P. | relative potency |
potency
| inactivated poliovirus vaccine | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
|---|---|
| inactivated polio vaccine | <pharmacology, virology> An inactivated vaccination, administered by injection to children for protection against the polio virus. Typically given at 2, 4 and 15 months. A final vaccine is recommended at 4-6 years. (27 Sep 1997) |
| poliovirus vaccine | A suspension of formalin-inactivated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used in the united states only for immunization of immunologically deficient patients and for primary immunization of unimmunised adults at risk. (12 Dec 1998) |
| poliovirus vaccine, oral | A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (12 Dec 1998) |
| oral poliovirus vaccine | An aqueous suspension of live, attenuated strains of poliomyelitis virus (types 1, 2, and 3) given orally for active immunization against poliomyelitis. See: Sabin vaccine. Synonym: poliomyelitis vaccines. (05 Mar 2000) |
| live oral poliovirus vaccine | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
| Allen video enhanced contrast | <procedure> A method for enhancing microscopic images pioneered by R D Allen. The digitised image has the background (an out of focus image of the same microscopic field with comparable unevenness of illumination etc.) subtracted and the contrast expanded to utilise the potential contrast range. Interestingly, it is possible to produce images of objects that are below the theoretical limit of resolution microtubules for example. (18 Nov 1997) |
| potency | Power, especially: 1. <gynaecology> The ability of the male to perform sexual intercourse. 2. <pharmacology> The power of a medicinal agent to produce the desired effects. 3. <anatomy> The ability of an embryonic part to develop and complete its destiny. Origin: L. Potentia = power (14 May 1997) |
| sexual potency | The ability to carry out and consummate sexual intercourse, usually referring to the male. (05 Mar 2000) |
| vaccines, inactivated | Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. (12 Dec 1998) |
| inactivated serum | <immunology> Serum that has been heated 50캜 for 30 minutes to destroy the lytic activity of complement. (05 Mar 2000) |
| poliovirus | <virology> A member of the enterovirus group of Picornaviridae that causes poliomyelitis. (18 Nov 1997) |
| poliovirus hominis | The picornavirus (genus Enterovirus) causing poliomyelitis in humans; the route of infection is the alimentary tract, but the virus may enter the bloodstream and nervous system, sometimes causing paralysis of the limbs and, rarely, encephalitis; many infections are inapparent; serologic types 1, 2, and 3 are recognised, type 1 being responsible for most paralytic poliomyelitis and most epidemics. Synonym: poliovirus hominis, poliovirus. (05 Mar 2000) |
| poliovirus vaccines | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
| acellular vaccine | <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells. (13 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|